Search Within

Alison Moskowitz

Formats
  1. Meeting Abstract (181)
  2. Journal Article (123)
  3. Review (13)
  4. Research Letter (12)
  5. Editorial (5)
  6. Guidelines (3)
  7. Book Section (1)
  8. Correspondence (1)
Groups
  1. Center for Hematologic Malignancies (339)
  2. Department of Medicine (339)
  3. Hematologic Malignancies, Division of (339)
  4. Lymphoma (339)
  5. Population Sciences Research Program (220)
  6. Survivorship Research (141)

More Groups

People
  1. Steven Horwitz (220)
  2. Andrew Zelenetz (119)
  3. Paul Hamlin (107)
  4. Ariela Noy (106)
  5. David Straus (96)
  6. Matthew Matasar (95)

More People

Years
  1. 2025 (6)
  2. 2024 (22)
  3. 2023 (37)
  4. 2022 (20)
  5. 2021 (36)
  6. 2020 (30)

More Years

Publications
  1. Blood (136)
  2. Hematological Oncology (23)
  3. Journal of Clinical Oncology (21)
  4. Blood Advances (15)
  5. Journal of the American Academy of Dermatology (13)
  6. Leukemia and Lymphoma (13)

More Publications

Publishers
  1. American Society of Hematology (154)
  2. Wiley Blackwell (31)
  3. American Society of Clinical Oncology (24)
  4. Elsevier Inc. (21)
  5. Taylor & Francis Group (14)
  6. Mosby Elsevier (13)

More Publishers

Results (339)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A novel JAK2 fusion in T-cell prolymphocytic leukemia
    Journal Article

    Eren, O. C.; Stuver, R.; Zhou, T.; Zaidinski, M.; Moskowitz, A. J.; Horwitz, S. M.; Ewalt, M. D.; Zhang, Y.; Lim, M. S.
    Genes Chromosomes and Cancer (2024)

    Fulltext@MSK | Save
  • Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: A propensity score–matched analysis
    Journal Article

    Driessen, J.; de Wit, F.; Herrera, A. F.; Zinzani, P. L.; LaCasce, A. S.; Cole, P. D.; Moskowitz, C. H.; García-Sanz, R.; Fuchs, M.; Müller, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma
    Research Letter

    Zinzani, P. L.; Salles, G.; Moskowitz, A. J.; Santoro, A.; Mehta, A.; Barr, P. M.; Mehta-Shah, N.; Collins, G. P.; Ansell, S. M.; Brody, J. D.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation
    Research Letter

    Stuver, R.; Mian, A.; Brown, S.; Devlin, S.; Caimi, P. F.; Chinapen, S.; Dahi, P.; Dean, R.; Epstein-Peterson, Z. D.; Hill, B.; more...
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
    Journal Article

    Bantilan, K. S.; Smith, A. N.; Maurer, M. J.; Teruya-Feldstein, J.; Matasar, M. J.; Moskowitz, A. J.; Straus, D. J.; Noy, A.; Palomba, M. L.; Horwitz, S. M.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation
    Journal Article

    Epstein-Peterson, Z. D.; Drill, E.; Aypar, U.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamlin, P. A.; Ho, C.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma
    Research Letter

    Stuver, R.; Noy, A.; Vardhana, S. A.; Zelenetz, A. D.; Moskowitz, A. J.
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Diffuse large B-cell lymphoma involving osseous sites: Utility of response assessment by PET/CT and good long-term outcomes
    Journal Article

    Ghione, P.; Ahsanuddin, S.; Luttwak, E.; Varela, S. B.; Nakajima, R.; Michaud, L.; Gupta, K.; Navitski, A.; Straus, D.; Palomba, M. L.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Engraftment syndrome during autologous stem cell transplant in Hodgkin lymphoma patients treated with checkpoint inhibitors: A multi-center retrospective analysis
    Meeting Abstract

    Taranto, E.; Hwang, W. T.; Alfaro, M.; Surapaneni, A. S.; Gill, S. K.; Feldman, T.; Randall, M. P.; Spinner, M. A.; Furqan, F.; Shah, N. N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Efficacy of brentuximab vedotin maintenance therapy following autologous stem cell transplantation in patients with relapsed/refractory classical Hodgkin lymphoma with and without pre-transplant exposure to novel agents
    Meeting Abstract

    Falade, A. S.; Redd, R. A.; Shah, H.; Baron, K.; Iyengar, S.; Desai, S. H.; Ansell, S. M.; Micallef, I.; Nedved, A.; Ganesan, N.; more...
    Blood (2023)

    Fulltext@MSK | Save